Exact Mass: 273.0399114
Exact Mass Matches: 273.0399114
Found 328 metabolites which its exact mass value is equals to given mass value 273.0399114,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
ADEFOVIR
C8H12N5O4P (273.06268819999997)
A member of the class of phosphonic acids that is methylphosphonic acid in which one of the methyl hydrogens has been replaced by a 2-(6-amino-9H-purin-9-yl)ethoxy group. An inhibitor of HIV-1 reverse transcriptase, the bis(t-butoxycarbonyloxymethyl) ester (dipivoxil ester) prodrug is used to treat chronic hepatitis B viral infection. C471 - Enzyme Inhibitor > C1589 - Reverse Transcriptase Inhibitor > C97452 - Nucleoside Reverse Transcriptase Inhibitor D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D018894 - Reverse Transcriptase Inhibitors D004791 - Enzyme Inhibitors > D019384 - Nucleic Acid Synthesis Inhibitors C254 - Anti-Infective Agent > C281 - Antiviral Agent Same as: D02768
Carprofen
Carprofen is a non-steroidal anti-inflammatory drug (NSAID) that is used by veterinarians as a supportive treatment for the relief of arthritic symptoms in geriatric dogs. Carprofen was previously used in human medicine for over 10 years (1985-1995). It was generally well tolerated, with the majority of adverse effects being mild, such as gastro-intestinal pain and nausea, similar to those recorded with aspirin and other non-steroidal anti-inflammatory drugs. It is no longer marketed for human usage, after being withdrawn on commercial grounds. [Wikipedia] C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D011838 - Radiation-Sensitizing Agents > D017319 - Photosensitizing Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents D003879 - Dermatologic Agents Carprofen is a nonsteroid anti-inflammatory agent, acts as a multi-target FAAH/COX inhibitor, with IC50s of 3.9 μM, 22.3 μM and 78.6 μM for COX-2, COX-1 and FAAH, respectively.
Tolcapone
Tolcapone is a drug that inhibits the enzyme catechol-O-methyl transferase (COMT). It is used in the treatment of Parkinsons disease as an adjunct to levodopa/carbidopa medication. It is a yellow, odorless, non-hygroscopic, crystalline compound. Tolcapone is associated with a risk of hepatotoxicity. [Wikipedia] D002491 - Central Nervous System Agents > D018726 - Anti-Dyskinesia Agents > D000978 - Antiparkinson Agents D004791 - Enzyme Inhibitors > D065098 - Catechol O-Methyltransferase Inhibitors N - Nervous system > N04 - Anti-parkinson drugs > N04B - Dopaminergic agents C78272 - Agent Affecting Nervous System > C38149 - Antiparkinsonian Agent
chlormezanone
M - Musculo-skeletal system > M03 - Muscle relaxants > M03B - Muscle relaxants, centrally acting agents > M03BB - Oxazol, thiazine, and triazine derivatives D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants D018373 - Peripheral Nervous System Agents > D009465 - Neuromuscular Agents C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent CONFIDENCE standard compound; INTERNAL_ID 1251; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3476; ORIGINAL_PRECURSOR_SCAN_NO 3474 CONFIDENCE standard compound; INTERNAL_ID 1251; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3477; ORIGINAL_PRECURSOR_SCAN_NO 3475 CONFIDENCE standard compound; INTERNAL_ID 1251; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3491; ORIGINAL_PRECURSOR_SCAN_NO 3489 CONFIDENCE standard compound; INTERNAL_ID 1251; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3493; ORIGINAL_PRECURSOR_SCAN_NO 3491 Chlormezanone resembles benzodiazepine. The action of Chlormezanone is similar to benzodiazepine-type agents. Chlormezanone is used as an anxiolytic and a muscle relaxant.
Ketamine hydrochloride
C13H17Cl2NO (273.06871320000005)
D018377 - Neurotransmitter Agents > D018683 - Excitatory Amino Acid Agents > D018691 - Excitatory Amino Acid Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D000777 - Anesthetics D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C245 - Anesthetic Agent D002491 - Central Nervous System Agents > D000700 - Analgesics
Chlormezanone
Chlormezanone is only found in individuals that have used or taken this drug. It is a non-benzodiazepine that is used in the management of anxiety. It has been suggested for use in the treatment of muscle spasm. [PubChem]Chlormezanone binds to central benzodiazepine receptors which interact allosterically with GABA receptors. This potentiates the effects of the inhibitory neurotransmitter GABA, increasing the inhibition of the ascending reticular activating system and blocking the cortical and limbic arousal that occurs following stimulation of the reticular pathways. M - Musculo-skeletal system > M03 - Muscle relaxants > M03B - Muscle relaxants, centrally acting agents > M03BB - Oxazol, thiazine, and triazine derivatives D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants D018373 - Peripheral Nervous System Agents > D009465 - Neuromuscular Agents C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent Chlormezanone resembles benzodiazepine. The action of Chlormezanone is similar to benzodiazepine-type agents. Chlormezanone is used as an anxiolytic and a muscle relaxant.
Modafinil
C15H15NO2S (273.08234500000003)
Modafinil is a stimulant drug marketed as a wakefulness promoting agent and is one of the stimulants used in the treatment of narcolepsy. Narcolepsy is caused by dysfunction of a family of wakefulness-promoting and sleep-suppressing peptides, the orexins, whose neurons are activated by modafinil. The prexin neuron activation is associated with psychoactivation and euphoria. The exact mechanism of action is unclear, although in vitro studies have shown it to inhibit the reuptake of dopamine by binding to the dopamine reuptake pump, and lead to an increase in extracellular dopamine. Modafinil activates glutamatergic circuits while inhibiting GABA. N - Nervous system > N06 - Psychoanaleptics > N06B - Psychostimulants, agents used for adhd and nootropics > N06BA - Centrally acting sympathomimetics D002491 - Central Nervous System Agents > D000697 - Central Nervous System Stimulants > D064690 - Wakefulness-Promoting Agents D065693 - Cytochrome P-450 Enzyme Inducers > D065701 - Cytochrome P-450 CYP3A Inducers COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C78272 - Agent Affecting Nervous System > C47795 - CNS Stimulant Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
Stepronin
Strepronin is a mucolytic drug. A mucolytic agent is any agent which dissolves thick mucus usually used to help relieve respiratory difficulties. The viscosity of mucous secretions in the lungs is dependent upon the concentrations of mucoprotein as well as the presence of disulfide bonds between these macromolecules and DNA. R - Respiratory system > R05 - Cough and cold preparations > R05C - Expectorants, excl. combinations with cough suppressants > R05CB - Mucolytics C78273 - Agent Affecting Respiratory System > C74536 - Mucolytic Agent D007155 - Immunologic Factors > D007166 - Immunosuppressive Agents D019141 - Respiratory System Agents > D005100 - Expectorants D000890 - Anti-Infective Agents > D000998 - Antiviral Agents
(2,5-Dioxopyrrolidin-1-yl) 5-(2-hydroxyethoxy)-4-oxopentanoate
C11H15NO7 (273.08484799999997)
(2,6-Dioxo-3H-purin-9-yl) pyridine-3-carboxylate
C11H7N5O4 (273.04980220000004)
Nebicapone
C78272 - Agent Affecting Nervous System > C38149 - Antiparkinsonian Agent C471 - Enzyme Inhibitor
Pomalidomide
C308 - Immunotherapeutic Agent > C129820 - Antineoplastic Immunomodulating Agent > C157388 - Immunomodulatory Imide Drug L - Antineoplastic and immunomodulating agents > L04 - Immunosuppressants > L04A - Immunosuppressants D006133 - Growth Substances > D043924 - Angiogenesis Modulating Agents D000970 - Antineoplastic Agents > D020533 - Angiogenesis Inhibitors C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor D006133 - Growth Substances > D006131 - Growth Inhibitors D007155 - Immunologic Factors
6-Imidazol-1-yl-7-nitro-1,4-dihydroquinoxaline-2,3-dione
C11H7N5O4 (273.04980220000004)
D018377 - Neurotransmitter Agents > D018683 - Excitatory Amino Acid Agents > D018691 - Excitatory Amino Acid Antagonists D002491 - Central Nervous System Agents > D018696 - Neuroprotective Agents D002491 - Central Nervous System Agents > D000927 - Anticonvulsants D020011 - Protective Agents
Cyclanilide
CONFIDENCE standard compound; INTERNAL_ID 615; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5409; ORIGINAL_PRECURSOR_SCAN_NO 5408 CONFIDENCE standard compound; INTERNAL_ID 615; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5394; ORIGINAL_PRECURSOR_SCAN_NO 5389 CONFIDENCE standard compound; INTERNAL_ID 615; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5361; ORIGINAL_PRECURSOR_SCAN_NO 5357 CONFIDENCE standard compound; INTERNAL_ID 615; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5400; ORIGINAL_PRECURSOR_SCAN_NO 5395 CONFIDENCE standard compound; INTERNAL_ID 615; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5404; ORIGINAL_PRECURSOR_SCAN_NO 5399 CONFIDENCE standard compound; INTERNAL_ID 615; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5366; ORIGINAL_PRECURSOR_SCAN_NO 5365
Brolamfetamine
D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017366 - Serotonin Receptor Agonists D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D006213 - Hallucinogens C78272 - Agent Affecting Nervous System > C47794 - Serotonin Agonist
(3R),5-dihydroxy-(4S)-methyl-3,4-dihydro-2,9,10-(2H)-1-azaanthracenetrione|laoticuzanone A
1-[2-(Methylthio)-4-hydroxy-6-(methylsulfinyl)phenylazo]formamide
Pomalidomide
C308 - Immunotherapeutic Agent > C129820 - Antineoplastic Immunomodulating Agent > C157388 - Immunomodulatory Imide Drug L - Antineoplastic and immunomodulating agents > L04 - Immunosuppressants > L04A - Immunosuppressants D006133 - Growth Substances > D043924 - Angiogenesis Modulating Agents D000970 - Antineoplastic Agents > D020533 - Angiogenesis Inhibitors C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor D006133 - Growth Substances > D006131 - Growth Inhibitors D007155 - Immunologic Factors
Tolcapone
D002491 - Central Nervous System Agents > D018726 - Anti-Dyskinesia Agents > D000978 - Antiparkinson Agents D004791 - Enzyme Inhibitors > D065098 - Catechol O-Methyltransferase Inhibitors N - Nervous system > N04 - Anti-parkinson drugs > N04B - Dopaminergic agents C78272 - Agent Affecting Nervous System > C38149 - Antiparkinsonian Agent CONFIDENCE standard compound; INTERNAL_ID 273; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4727; ORIGINAL_PRECURSOR_SCAN_NO 4722 CONFIDENCE standard compound; INTERNAL_ID 273; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4810; ORIGINAL_PRECURSOR_SCAN_NO 4806 CONFIDENCE standard compound; INTERNAL_ID 273; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4841; ORIGINAL_PRECURSOR_SCAN_NO 4839 CONFIDENCE standard compound; INTERNAL_ID 273; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4812; ORIGINAL_PRECURSOR_SCAN_NO 4809 CONFIDENCE standard compound; INTERNAL_ID 273; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4900; ORIGINAL_PRECURSOR_SCAN_NO 4896 CONFIDENCE standard compound; INTERNAL_ID 273; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4752; ORIGINAL_PRECURSOR_SCAN_NO 4748
provigil
C15H15NO2S (273.08234500000003)
N - Nervous system > N06 - Psychoanaleptics > N06B - Psychostimulants, agents used for adhd and nootropics > N06BA - Centrally acting sympathomimetics D002491 - Central Nervous System Agents > D000697 - Central Nervous System Stimulants > D064690 - Wakefulness-Promoting Agents D065693 - Cytochrome P-450 Enzyme Inducers > D065701 - Cytochrome P-450 CYP3A Inducers COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C78272 - Agent Affecting Nervous System > C47795 - CNS Stimulant Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
Stepronin
R - Respiratory system > R05 - Cough and cold preparations > R05C - Expectorants, excl. combinations with cough suppressants > R05CB - Mucolytics C78273 - Agent Affecting Respiratory System > C74536 - Mucolytic Agent D007155 - Immunologic Factors > D007166 - Immunosuppressive Agents D019141 - Respiratory System Agents > D005100 - Expectorants D000890 - Anti-Infective Agents > D000998 - Antiviral Agents
4-[4-(Trifluoromethyl)phenyl]-1,3-thiazole-2-carboxylic acid
C11H6F3NO2S (273.00713320000006)
2-Methoxy-3-nitro-[1,1-biphenyl]-3-carboxylic acid
1-(3,5-DICHLORO-2-HYDROXYPHENYL)-3-(2-FURYL)PROP-2-EN-1-ONE
Ethanone,1-(2,4-dihydroxyphenyl)-2-(4-nitrophenyl)-
1-(4-MORPHOLINYL)-2-(4-BROMO-1H-PYRAZOL-1-YL)ETHANONE
2-(4-Amino-2-Methyl-phenyl)-1,1,1,3,3,3-hexafluoro-propan-2-ol
C10H9F6NO (273.05882959999997)
6-fluoro-4-(trifluoromethyl)quinoline-2-carbohydrazide
N-(4-BROMO-2,6-DIMETHYLPHENYL)HYDRAZINECARBOTHIOAMIDE
C9H12BrN3S (272.99352519999997)
2,4-Dichloropyridine-3-boronic acid pinacol ester
C11H14BCl2NO2 (273.04945940000005)
2-(4-methylphenyl)sulfonyl-1,3-dihydroisoindole
C15H15NO2S (273.08234500000003)
3-AMINO-3-(2-BROMO-5-METHOXY-PHENYL)-PROPIONIC ACID
3-AMINO-3-(3-BROMO-4-METHOXY-PHENYL)-PROPIONIC ACID
3-AMINO-3-(5-BROMO-2-METHOXY-PHENYL)-PROPIONIC ACID
3-amino-3-(1,3-benzodioxol-5-yl)-2,2-dimethylpropanoic acid,hydrochloride
2-Acetoxy-N,N,N-trimethylethanaminium iodide
Acetylcholine iodide (ACh iodide) is a common neurotransmitter found in the central and peripheral nerve system[1].
4-(1-Piperazinyl)-1H-indole dihydrochloride
C12H17Cl2N3 (273.07994620000005)
2-[2-(2-amino-4-thiazolyl)ethyl]-1H-Isoindole-1,3(2H)-dione
3-[5-(2-METHYL-4-NITRO-PHENYL)-FURAN-2-YL]-ACRYLIC ACID
5-amino-2-(2,6-dioxopiperidin-3-yl)isoindole-1,3-dione
3-(3-NITROPHENYL)-5-(THIOPHEN-2-YL)-1,2,4-OXADIAZOLE
4-(Aminomethyl)-4-(3,4-dichlorophenyl)cyclohexanol
C13H17Cl2NO (273.06871320000005)
1,1,1,3,3,3-HEXAFLUORO-2-(4-(METHYLAMINO)PHENYL)PROPAN-2-OL
C10H9F6NO (273.05882959999997)
7-chloro-2-ethyl-5-(trifluoromethyl)-1H-pyrrolo[3,2-b]pyridine-6-carbonitrile
6,7-Dimethoxy-4-(trifluoromethyl)quinolin-2(1H)-one
esketamine hydrochloride
C13H17Cl2NO (273.06871320000005)
C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent
METHYL3-{[2-(DIAMINOMETHYLENEAMINO)THIAZOL-4-YL]METHYLTHIO}PROPANIMIDATE
5-Nitro-2-(3-piperidinylmethoxy)pyridinehydrochloride
C11H16ClN3O3 (273.08801359999995)
2,3-dichloro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine
C11H14BCl2NO2 (273.04945940000005)
4-(aminomethyl)-4-(3,4-dichlorophenyl)cyclohexan-1-ol
C13H17Cl2NO (273.06871320000005)
Methoxypolyethylene glycol succinate N-hydroxysuccinimide
C11H15NO7 (273.08484799999997)
4-Hydroxy-6-(trifluoromethoxy)quinoline-3-carboxylic acid
1-amino-2-chloro-4-hydroxyanthraquinone
C14H8ClNO3 (273.01926879999996)
2,5-Dichloropyridine-4-boronic acid pinacol ester
C11H14BCl2NO2 (273.04945940000005)
2,5-Dichloropyridine-3-boronic acid pinacol ester
C11H14BCl2NO2 (273.04945940000005)
2,3-Dichloropyridine-4-boronic acid pinacol ester
C11H14BCl2NO2 (273.04945940000005)
2-(4-methoxy-N-methylsulfonylanilino)propanoic acid
2-Bromo-1-[(2-methyl-2-propanyl)oxy]-4-nitrobenzene
3,5-Dichloro-4-pyridineboronic acid pinacol ester
C11H14BCl2NO2 (273.04945940000005)
4-[(Cyclopropylcarbonyl)amino]-2-(trifluoromethyl)benzoic acid
3-(2-PHENYL-IMIDAZOL-1-YL)-PROPYLAMINE DIHYDROCHLORIDE
C12H17Cl2N3 (273.07994620000005)
5,6-dimethoxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid,hydrochloride
2-[4-(trifluoromethyl)phenyl]-1,3-thiazole-4-carboxylic acid
C11H6F3NO2S (273.00713320000006)
(S)-(-)- 6,7-DIMETHOXY-1,2,3,4-TETRAHYDROISOQUINOLINE-3- CARBOXYLIC ACID HYDROCHLORIDE
6-nitro-4-oxo-7-propan-2-yloxy-1H-quinoline-3-carbonitrile
1-(7-CHLOROTHIAZOLO[5,4-D]PYRIMIDIN-2-YL)-1,3-DIMETHYLTHIOUREA
2-Chloro-6-(4-(3-fluorophenyl)-1H-imidazol-2-yl)pyridine
2-((5-BROMOPYRAZIN-2-YL)OXY)-N,N-DIETHYLETHANAMINE
[2-[(tert-Butoxycarbonyl)amino]pyrimidin-5-yl]boronic acid
5-(CHLOROMETHYL)-3-[(2-PYRIDYLSULFONYL)METHYL]-1,2,4-OXADIAZOLE
2,6-Dichloropyridine-4-boronic acid, pinacol ester
C11H14BCl2NO2 (273.04945940000005)
2-Pyridin-4-yl-benzo[h]chromen-4-one
D004791 - Enzyme Inhibitors > D001571 - Benzoflavones
Ethyl morpholine-2-carboxylate 2,2,2-trifluoroacetate
2-((6-Chloropyridazin-3-yl)methyl)isoindoline-1,3-dione
C13H8ClN3O2 (273.03050179999997)
1-(4-Bromo-2-chlorobenzyl)pyrrolidine
C11H13BrClN (272.9919828000001)
(3-(N-isopropylsulfamoyl)-4-Methoxyphenyl)boronic acid
C10H16BNO5S (273.08421960000004)
5-propan-2-yl-7-(trifluoromethyl)pyrazolo[1,5-a]pyrimidine-2-carboxylic acid
(-)-n,n-dimethylephedrinium bromide
C12H20BrNO (273.07281700000004)
2-(4-AMINO-3-METHYLPHENYL)HEXAFLUOROISOPROPANOL
C10H9F6NO (273.05882959999997)
Methyl 2-amino-5-(3-chloropropoxy)-4-methoxybenzoate
6-(5-Chloro-1H-pyrrolo[2,3-b]pyridin-3-yl)nicotinic acid
C13H8ClN3O2 (273.03050179999997)
2-(4-BROMO-PHENYL)-7-METHYL-IMIDAZO[1,2-A]PYRIMIDINE
2-[(5-METHYLTHIENO[2,3-D]PYRIMIDIN-4-YL)THIO]ANILINE
2,6-Dichloropyridine-3-boronic acid pinacol ester
C11H14BCl2NO2 (273.04945940000005)
2-Methyl-2-propanyl 5-bromo-2-oxo-1,2-dihydro-3-pyridinecarboxyla te
2-(Benzofuran-2-yl)-6-methyl-1,3,6,2-dioxazaborocane-4,8-dione,2-Benzofuranboronic acid MIDA ester
2-(2-Amino-4-Methyl-phenyl)-1,1,1,3,3,3-hexafluoro-propan-2-ol
C10H9F6NO (273.05882959999997)
armodafinil
C15H15NO2S (273.08234500000003)
N - Nervous system > N06 - Psychoanaleptics > N06B - Psychostimulants, agents used for adhd and nootropics > N06BA - Centrally acting sympathomimetics D002491 - Central Nervous System Agents > D000697 - Central Nervous System Stimulants > D064690 - Wakefulness-Promoting Agents D065693 - Cytochrome P-450 Enzyme Inducers > D065701 - Cytochrome P-450 CYP3A Inducers C78272 - Agent Affecting Nervous System > C47795 - CNS Stimulant
6-[N-(2-chloropyrimidin-4-yl)amino]-2,3-dimethyl-2H-indazole
2-[(2-Aminothiazol-4-yl)carboxymethyleneaminooxy]-2-methylpropionic acid
C9H11N3O5S (273.04193960000003)
(4-METHYL-2-[3-(TRIFLUOROMETHYL)PHENYL]-1,3-THIAZOL-5-YL)METHANOL
(Z)-2-(2-Aminothiazol-4-yl)-2-(1-carboxy-1-methyl)ethoxyiminoacetic acid
C9H11N3O5S (273.04193960000003)
5-(Hydroxymethyl)-4-methyl-2-(4-trifluoromethylphenyl)thiazole
(4-boronophenyl)methyl-trimethylazanium,bromide
C10H17BBrNO2 (273.05356320000004)
2-(1,3-Benzodioxol-5-yl)-6-chloroimidazo[1,2-b]pyridazine
C13H8ClN3O2 (273.03050179999997)
4-METHYL-N-(4-METHYL-BENZYLIDENE)BENZENESULFONAMIDE
C15H15NO2S (273.08234500000003)
2-(tert-Butylamino)-3,4-chloropropiophenone hydrochloride
C13H17Cl2NO (273.06871320000005)
2-[3-(Trifluoromethyl)phenyl]-1,3-thiazole-4-carboxylic acid
C11H6F3NO2S (273.00713320000006)
(S)-6,7 DIMETHOXY 1,2,3,4 TETRAHYDRO-ISOQUINOLINE-3-CARBOXYLOIC ACID HYDROCHLORIDE
4-(6-Chloro-2-Methylsulfanyl-pyriMidin-4-ylaMino)-cyclohexanol
[1-(2,6-Dichloro-benzyl)-piperidin-2-yl]-methanol
C13H17Cl2NO (273.06871320000005)
(2-{[1-Ethyl-3-(trifluoromethyl)-1H-pyrazol-5-yl]methoxy}ethyl)amine hydrochloride
1-(4-METHOXY-2-NITROPHENYL)PIPERAZINE HYDROCHLORIDE
C11H16ClN3O3 (273.08801359999995)
2-(2-amino-5-methyl-phenyl)-1,1,1,3,3,3-hexafluoro-propan-2-ol
C10H9F6NO (273.05882959999997)
1-(1-methylpyrazol-4-yl)sulfonylpiperidine-4-carboxylic acid
2-acetyl-1,2,3,4-tetrahydroisoquinoline-7-sulfonyl chloride
2-((3-CHLOROPYRAZIN-2-YL)METHYL)ISOINDOLINE-1,3-DIONE
C13H8ClN3O2 (273.03050179999997)
2-METHYL-5-(2-OXO-PYRROLIDIN-1-YL)-BENZENESULFONYL CHLORIDE
{[5-(CYCLOHEXYLAMINO)-1,3,4-THIADIAZOL-2-YL]THIO}ACETIC ACID
1-(3,4-DICHLOROPHENYL)-5-OXO-3-PYRROLIDINECARBOXYLIC ACID
N-(2-aminopyrimidin-5-yl)-2-methyl-5-nitrobenzamide
(R,R)-N,N-BIS(TRIFLUOROMETHANESULFONYL)-1,2-DIPHENYLETHYLENEDIAMINE
2-(4-acetylpiperazin-1-yl)-4-chloro-1,3-thiazole-5-carbaldehyde
1-PROPIONYL-2,3-DIHYDRO-1H-INDOLE-5-SULFONYL CHLORIDE
6-phosphonatooxy-D-gluconate
C6H10O10P-3 (273.00115900000003)
COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
4,7-Methano-1H-(1,2)diazeto(3,4-f)benzotriazole, 1-(4-chlorophenyl)-3a,4,4a,6a,7,7a-hexahydro-
3,5-dichloro-N-(2-methyl-3-oxobutan-2-yl)benzamide
2-[(2,4-Dichlorophenyl)methyl]-4,4-dimethyl-1,2-oxazolidin-3-one
2-(2,5-Dimethylphenyl)-6-fluoro-1,2-benzothiazol-3-one
(R)-Carprofen
COVID info from PDB, Protein Data Bank Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
2-methyl-N-[(E)-(2-nitrophenyl)methylideneamino]furan-3-carboxamide
4-phenyl-3-(thiophen-2-ylmethyl)-1H-1,2,4-triazole-5-thione
N4-(1,1-dioxo-3-thiolanyl)-5-nitropyrimidine-4,6-diamine
2-[(4-Chloro-2-methylphenoxy)methyl]imidazo[1,2-a]pyrimidine
3-(4-chlorophenyl)-2,5-dimethyl-1H-pyrazolo[1,5-a]pyrimidin-7-one
2-(4-Chlorophenoxy)-4-(dimethylamino)-3-pyridinecarbonitrile
2-methoxy-N-[2-(methylthio)phenyl]benzamide
C15H15NO2S (273.08234500000003)
2-amino-7-fluoro-5-oxo-5H-chromeno[2,3-b]pyridine-3-carboxamide
1-[(2,6-Dichlorophenyl)carbamoyl]cyclopropane-1-carboxylic acid
2-C-((phosphooxy)methyl)-D-ribonic acid
C6H10O10P-3 (273.00115900000003)
Ketalar
C13H17Cl2NO (273.06871320000005)
D018377 - Neurotransmitter Agents > D018683 - Excitatory Amino Acid Agents > D018691 - Excitatory Amino Acid Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D000777 - Anesthetics D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics
2-Methyl-5-[(2-methyl-4-quinolinyl)thio]-1,3,4-thiadiazole
N-(4-fluorophenyl)-2,1,3-benzothiadiazole-5-carboxamide
C13H8FN3OS (273.03720899999996)
N-(4-methoxyphenyl)-2-(methylthio)benzamide
C15H15NO2S (273.08234500000003)
5-Chloropyridin-3-yl benzofuran-2-carboxylate
C14H8ClNO3 (273.01926879999996)
(4-Amino-3-ethyl-2-sulfanylidene-5-thiazolyl)-(4-morpholinyl)methanone
2-methyl-N-[(E)-(2-nitrophenyl)methylideneamino]pyrazole-3-carboxamide
N-(5-fluoro-2-methylphenyl)-1,3-benzodioxole-5-carboxamide
N-[(3-methyl-6-imidazo[2,1-b]thiazolyl)methyl]-1-propanesulfonamide
2-(2,4-Dimethylphenyl)-6-fluoro-1,2-benzothiazol-3-one
N-(1-benzothiophen-7-ylmethyl)-2-thiophenecarboxamide
N-[4-cyano-5-methyl-2-oxo-3-(trifluoromethyl)-1H-pyrrol-3-yl]cyclopropanecarboxamide
2-carboxylato-D-arabinitol 1-phosphate(3-)
C6H10O10P-3 (273.00115900000003)
5-ethyl-3-(5-oxo-2-sulfanylidene-4-imidazolidinylidene)-1H-indol-2-one
3-(1,3-Benzoxazol-2-ylsulanyl)-5,5-dimethylcyclohex-2-en-1-one
C15H15NO2S (273.08234500000003)
2-(4-chlorophenyl)-N-[(E)-pyridin-4-ylmethylideneamino]acetamide
2,4,7,9-tetrahydroxy-6-methyl-1-oxo-1H-phenalen-3-olate
6-phospho-2-dehydro-D-gluconate(1-)
C6H10O10P- (273.00115900000003)
[(2S)-2,3-dihydroxypropyl] [(2S)-3-formyloxy-2-hydroxypropyl] phosphate
(2R)-2-amino-3-(1-carboxy-2-sulfoethyl)sulfanylpropanoic acid
2-(N-Benzyloxycarbonyl-N-methylamino)ethylphosphonic acid
carprofen
C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D011838 - Radiation-Sensitizing Agents > D017319 - Photosensitizing Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents D003879 - Dermatologic Agents Carprofen is a nonsteroid anti-inflammatory agent, acts as a multi-target FAAH/COX inhibitor, with IC50s of 3.9 μM, 22.3 μM and 78.6 μM for COX-2, COX-1 and FAAH, respectively.
6-phosphonatooxy-D-gluconate
C6H10O10P (273.00115900000003)
An organophosphate oxoanion that is a trianion arising from deprotonation of phosphate and carboxylic acid functions of 6-phospho-D-gluconic acid.
RH-24580
A methyl ketone resulting from the formal hydration of the ethynyl group of the herbicide propyzamide. It is a major soil metabolite of propyzamide.
GABAA receptor agent 1
C13H8ClN3O2 (273.03050179999997)
GABAA receptor agent 1 is a high affinity ligand for GABAA receptor, with potent anticonvulsant activity[1].
8,10-dimethoxy-4,12,14-trioxa-2-azatetracyclo[7.7.0.0³,⁷.0¹¹,¹⁵]hexadeca-1(16),2,5,7,9,11(15)-hexaene
4-hydroxy-2-{[hydroxy(2-hydroxyphenyl)methylidene]amino}benzoic acid
16-methoxy-2-methyl-4,12,14-trioxa-2-azatetracyclo[7.7.0.0³,⁷.0¹¹,¹⁵]hexadeca-1(16),3(7),5,9,11(15)-pentaen-8-one
2-benzamidobenzoic acid; 2',4-dihydroxy
{"Ingredient_id": "HBIN005343","Ingredient_name": "2-benzamidobenzoic acid; 2',4-dihydroxy","Alias": "NA","Ingredient_formula": "C14H11NO5","Ingredient_Smile": "NA","Ingredient_weight": "273.24","OB_score": "NA","CAS_id": "115610-40-7","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "8694","PubChem_id": "NA","DrugBank_id": "NA"}